Haematologica
HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thiele, J
Right arrow Articles by Orazi, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thiele, J
Right arrow Articles by Orazi, A
Haematologica, Vol 90, Issue 8, 1128-1132
Copyright © 2005 by Ferrata Storti Foundation

Comparative Study

European consensus on grading bone marrow fibrosis and assessment of cellularity

J Thiele, HM Kvasnicka, F Facchetti, V Franco, J van der Walt, and A Orazi

Institute for Pathology, University of Cologne, Germany. j.thiele@uni-koeln.de

Quantification of characteristic bone marrow biopsy features includes basic parameters such as cellularity and fiber content. These are important to assess the dynamics of disease processes with a significant impact on risk stratification, survival patterns and, especially, therapy-related changes. A panel of experienced European pathologists and a foreign expert evaluated, at a multi-headed microscope, a large number of representative slides of trephine biopsies from patients with myelofibrosis in an attempt to reach a consensus on how to grade cellularity and fibrosis. This included a critical evaluation of previously described scoring systems. During the microscopic analysis and subsequent discussion and voting, the importance of age-dependent decrease in cellularity was recognized. Grading of myelofibrosis was simplified by using four easily reproducible categories including differentiation between reticulin and collagen. A consensus was reached that the density of fibers must be assessed in relation to the hematopoietic tissue. This feature is especially important in order to avoid a false impression of a reduced fiber content in fatty and/or edematous bone marrow samples after treatment. The consensus for measuring myelofibrosis by clear and reproducible guidelines achieved by our group should allow for precise grading during the disease process and after therapy.


This article has been cited by other articles:


Home page
 haematolHome page
F. Passamonti, E. Rumi, L. Arcaini, E. Boveri, C. Elena, D. Pietra, S. Boggi, C. Astori, P. Bernasconi, M. Varettoni, et al.
Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients
Haematologica, November 1, 2008; 93(11): 1645 - 1651.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
A Tzankov, K Sotlar, D Muhlematter, A Theocharides, P Went, M Jotterand, H-P Horny, and S Dirnhofer
Systemic mastocytosis with associated myeloproliferative disease and precursor B lymphoblastic leukaemia with t(13;13)(q12;q22) involving FLT3
J. Clin. Pathol., August 1, 2008; 61(8): 958 - 961.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. M. Vannucchi, E. Antonioli, P. Guglielmelli, A. Pancrazzi, V. Guerini, G. Barosi, M. Ruggeri, G. Specchia, F. Lo-Coco, F. Delaini, et al.
Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia
Blood, August 1, 2008; 112(3): 844 - 847.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
O. Bock, J. Hoftmann, K. Theophile, K. Hussein, B. Wiese, J. Schlue, and H. Kreipe
Bone Morphogenetic Proteins Are Overexpressed in the Bone Marrow of Primary Myelofibrosis and Are Apparently Induced by Fibrogenic Cytokines
Am. J. Pathol., April 1, 2008; 172(4): 951 - 960.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. Vener, N. S. Fracchiolla, U. Gianelli, R. Calori, F. Radaelli, A. Iurlo, S. Caberlon, G. Gerli, L. Boiocchi, and G. L. Deliliers
Prognostic implications of the European consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis
Blood, February 15, 2008; 111(4): 1862 - 1865.
[Abstract] [Full Text] [PDF]

Home page
 haematolHome page
A. Tefferi
Primary myelofibrosis and its paraneoplastic stromal effects
Haematologica, May 1, 2007; 92(5): 577 - 579.
[Full Text] [PDF]

Home page
 BloodHome page
A. Tefferi, G. Barosi, R. A. Mesa, F. Cervantes, H. J. Deeg, J. T. Reilly, S. Verstovsek, B. Dupriez, R. T. Silver, O. Odenike, et al.
International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT)
Blood, September 1, 2006; 108(5): 1497 - 1503.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
O. Bock, J. Neuse, K. Hussein, K. Brakensiek, G. Buesche, T. Buhr, B. Wiese, and H. Kreipe
Aberrant Collagenase Expression in Chronic Idiopathic Myelofibrosis Is Related to the Stage of Disease but Not to the JAK2 Mutation Status
Am. J. Pathol., August 1, 2006; 169(2): 471 - 481.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
T. Horn, M. Kremer, T. Dechow, W. M. Pfeifer, B. Geist, M. Perker, J. Duyster, L. Quintanilla-Martinez, and F. Fend
Detection of the Activating JAK2 V617F Mutation in Paraffin-Embedded Trephine Bone Marrow Biopsies of Patients with Chronic Myeloproliferative Diseases
J. Mol. Diagn., July 1, 2006; 8(3): 299 - 304.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
F. Passamonti, E. Rumi, D. Pietra, M. G. D. Porta, E. Boveri, C. Pascutto, L. Vanelli, L. Arcaini, S. Burcheri, L. Malcovati, et al.
Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders
Blood, May 1, 2006; 107(9): 3676 - 3682.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
Copyright © 2005 by the Ferrata Storti Foundation.